Japanese Preprint Study Urges Halt on mRNA Vaccines Amid Blood Bank Contamination Fears
Medical professionals are being urged to consider the potential risks associated with blood transfusions using blood products from individuals who have experienced long COVID or have been recipients of genetic vaccines, including mRNA vaccines. This caution comes amidst growing concerns over the unknown effects such vaccines may have on blood products and the possible health risks involved.
A groundbreaking study published earlier this month in Preprints.org by a team of researchers led by Jun Ueda at the Asahikawa Medical University, Hokkaido, Japan, has ignited a global conversation about the safety of blood transfusions from donors vaccinated against COVID-19 with genetic vaccines.
The World Health Organization declared the coronavirus pandemic in March 2020, leading to an unprecedented global vaccination effort.
